NIPT

NIPT is a screening test, not a diagnostic test. A high-risk result indicates increased probability of a chromosomal condition but does not confirm a diagnosis. For definitive diagnosis, invasive procedures such as amniocentesis or chorionic villus sampling (CVS) are required. However, NIPT's greater than 99% accuracy has dramatically reduced the need for invasive testing — leading to a 94.8% reduction in invasive procedures and a 90.8% decrease in procedure-related miscarriages.

As per the Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act, disclosure of fetal sex is prohibited in India. This is a legal requirement we strictly follow. While sex chromosomal aneuploidies are screened and reported in terms of chromosomal health risk, the sex of the fetus is never disclosed in our reports.

10 ml of blood is drawn from the pregnant mother's arm into a specialized Streck tube (which preserves cell-free DNA). This can be done at home if you have a trained phlebotomist available, or at any pathology lab near you. The Streck tube ensures sample stability during transport. No fasting is required and there is no risk to the baby whatsoever — this is a completely non-invasive test.

A high-risk result means increased probability of a chromosomal condition — it does not confirm a diagnosis. Our Genomic Expert will contact you to review the result in detail and discuss next steps, which typically include confirmatory diagnostic testing (amniocentesis or CVS) and referral to a maternal-fetal medicine specialist or genetic counselor. We will guide you through every step of the process.